Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways

被引:81
作者
Ni, Lei [1 ]
Feng, Yun [1 ]
Wan, Huanying [1 ]
Ma, Qinyun [2 ]
Fan, Liang [1 ]
Qian, Yanrong [1 ]
Li, Qingyun [1 ]
Xiang, Yi [1 ]
Gao, Beili [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Respirat, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Shanghai Inst Endocrinol, Ctr Mol Med,Ruijin Hosp,Sch Med, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金;
关键词
angiotensin-(1-7); MMPs; PI3K/Akt; MAPK; non-small cell lung cancer; CONVERTING ENZYME 2; MATRIX METALLOPROTEINASES; RECEPTOR BLOCKERS; CANCER; GROWTH; ANGIOGENESIS; EXPRESSION; XENOGRAFTS; REDUCTION; STRESS;
D O I
10.3892/or.2011.1554
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The local renin-angiotensin system (RAS) is one of the crucial components in the tumor microenvironment. Recent evidence suggests that the local RAS plays an important role in tumor metabolism, survival, angiogenesis and invasion processes. Angiotensin-(1-7) [Ang-(1-7)] is an endogenous peptide of the RAS with vasodilator and anti-proliferative properties. Previous studies have demonstrated that Ang-(1-7) inhibits both the growth of human lung cancer cells in vitro and tumor angiogenesis in vivo through activation of the MAS receptor. This study investigated the anti-metastatic effect of Ang-(1-7) in A549 human lung adenocarcinoma cells in vitro. We found that Ang-(1-7) reduced the cell migratory and invasive abilities by reducing the expression and activity of MMP-2 and MMP-9. Furthermore, we demonstrated that the anti-migration and anti-invasion effect of Ang-(1-7) was mediated through inactivation of the PI3K/Akt, P38 and JNK signal pathways. Our results suggest that Ang-(1-7) may have therapeutic potential against advanced lung carcinoma as a new agent.
引用
收藏
页码:783 / 790
页数:8
相关论文
共 37 条
[1]  
[Anonymous], CA CANC J CLIN, DOI DOI 10.3322/CAAC.20107
[2]   Antihypertensives as novel antineoplastics: Angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma - Discussion [J].
Brennan, Murray F. ;
Riall, Taylor S. ;
Nealon, William H. ;
Arafat, Hwyda A. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 204 (05) :1005-1006
[3]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[4]   Regulation of matrix metalloproteinases: An overview [J].
Chakraborti, S ;
Mandal, M ;
Das, S ;
Mandal, A ;
Chakraborti, T .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 253 (1-2) :269-285
[5]   Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells [J].
Chien, Chi-Sheng ;
Shen, Kun-Hung ;
Huang, Jau-Shyang ;
Ko, Shian-Chin ;
Shih, Yuan-Wei .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2010, 333 (1-2) :169-180
[6]   Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial [J].
Christian, Jennifer B. ;
Lapane, Kate L. ;
Hume, Anne L. ;
Eaton, Charles B. ;
Weinstock, Martin A. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (17) :1223-1232
[7]   Angiotensin receptors: a new role in cancer? [J].
Deshayes, F ;
Nahmias, C .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (07) :293-299
[8]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[9]   International comparisons of survival from lung cancer: pitfalls and warnings [J].
Erridge, Sara C. ;
Moller, Henrik ;
Price, Allan ;
Brewster, David .
NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (10) :570-577
[10]   Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro [J].
Feng, Yun ;
Ni, Lei ;
Wan, Huanying ;
Fan, Liang ;
Fei, Xiaochun ;
Ma, Qinyun ;
Gao, Beili ;
Xiang, Yi ;
Che, Jiaming ;
Li, Qingyun .
ONCOLOGY REPORTS, 2011, 26 (05) :1157-1164